Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Data for [177Lu]PP-F11N presented for medullary thyroid carcinoma

March 25, 2019

Nanoparticle MRI contrast agent SN-132D shows preclinical efficacy and safety

March 5, 2019

Servicios Cientificos Neuroinnovation patents tau protein ligands

Feb. 26, 2019

Tumor-specific near-infrared agent targeting PSMA for fluorescence-guided surgery in prostate cancer

Feb. 12, 2019

A11 Mb-IRDye800CW is a promising new probe for real-time fluorescence imaging in prostate cancer

Feb. 8, 2019

Guerbet identifies new compounds for liver cancer

Feb. 5, 2019

Study determines radiation dose of tau-selective radiotracer 18F-APN-1607

Jan. 25, 2019

[18F]RO-948 PET differentiates Alzheimer's disease from other neurodegenerative conditions

Jan. 24, 2019

First patient enrolled in phase II study of ImaginAb's CD8+ T-cell Immuno-PET imaging agent

Jan. 22, 2019

EMA grants marketing authorization for macimorelin

Jan. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...